Opportunity ID: 282115

General Information

Document Type: Grants Notice
Funding Opportunity Number: PAR-16-129
Funding Opportunity Title: Countermeasures Against Chemical Threats (CounterACT): Identification of Therapeutic Lead Compounds (U01)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Cooperative Agreement
Category of Funding Activity: Environment
Health
Category Explanation:
Expected Number of Awards:
Assistance Listings: 93.113 — Environmental Health
Cost Sharing or Matching Requirement: No
Version: Synopsis 2
Posted Date: Mar 10, 2016
Last Updated Date: Jun 15, 2016
Original Closing Date for Applications: Sep 11, 2018
Current Closing Date for Applications: Jun 15, 2016
Archive Date: Jul 15, 2016
Estimated Total Program Funding:
Award Ceiling: $300,000
Award Floor:

Eligibility

Eligible Applicants: Small businesses
Native American tribal governments (Federally recognized)
Public and State controlled institutions of higher education
City or township governments
Special district governments
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Others (see text field entitled “Additional Information on Eligibility” for clarification)
Public housing authorities/Indian housing authorities
Private institutions of higher education
Independent school districts
County governments
Native American tribal organizations (other than Federally recognized tribal governments)
State governments
For profit organizations other than small businesses
Additional Information on Eligibility: Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.

Additional Information

Agency Name: National Institutes of Health
Description: The mission of the NIH Countermeasures Against Chemical Threats (CounterACT) program is to develop new and improved therapeutics to treat and/or prevent injuries resulting from exposure to chemical threats. Chemical threats are toxic chemicals that could be used in a terrorist attack or accidentally released from industrial production, storage or shipping. They include traditional chemical warfare agents and toxic industrial chemicals and materials. This Funding Opportunity Announcement (FOA) requests new research applications for Cooperative Agreement Research Projects (U01s) seeking support for research on the identification of small molecule or biologic lead compounds that are excellent candidates for therapeutic development. The scope of research supported by this FOA includes confirmation of molecular targets for therapeutic development, demonstration of in vitro activity of candidate therapeutics, preliminary in vivo proof-of-concept efficacy data, preliminary adsorption, distribution, metabolism, excretion, and toxicity (ADME/Tox) evaluations and pharmacokinetics/pharmacodynamics (PK/PD) data. These studies must result in the identification of at least one lead compound ready for advanced therapeutic development. Lead compounds are biologically active and synthetically feasible compounds where specificity, affinity, potency, target selectivity, efficacy, and safety have been established. Lead compounds should be ready for more advanced development under possible support from other programs such as the one described in the companion FOA “CounterACT Optimization of Therapeutic Lead Compound (U01)” (PAR-16-XXX). The scope of this FOA encompasses Technical Readiness Level (TRL) 3 – see TRLs. Each project must include annual milestones that create discrete go or no-go decision points in a progressive translational study plan.
Link to Additional Information: http://grants.nih.gov/grants/guide/pa-files/PAR-16-129.html
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

NIH OER Webmaster

FBOWebmaster@OD.NIH.GOV

Email:FBOWebmaster@OD.NIH.GOV

Version History

Version Modification Description Updated Date
Expired and re-issued as PAR-16-330 Jun 15, 2016
Jun 15, 2016

DISPLAYING: Synopsis 2

General Information

Document Type: Grants Notice
Funding Opportunity Number: PAR-16-129
Funding Opportunity Title: Countermeasures Against Chemical Threats (CounterACT): Identification of Therapeutic Lead Compounds (U01)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Cooperative Agreement
Category of Funding Activity: Environment
Health
Category Explanation:
Expected Number of Awards:
Assistance Listings: 93.113 — Environmental Health
Cost Sharing or Matching Requirement: No
Version: Synopsis 2
Posted Date: Mar 10, 2016
Last Updated Date: Jun 15, 2016
Original Closing Date for Applications: Sep 11, 2018
Current Closing Date for Applications: Jun 15, 2016
Archive Date: Jul 15, 2016
Estimated Total Program Funding:
Award Ceiling: $300,000
Award Floor:

Eligibility

Eligible Applicants: Small businesses
Native American tribal governments (Federally recognized)
Public and State controlled institutions of higher education
City or township governments
Special district governments
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Others (see text field entitled “Additional Information on Eligibility” for clarification)
Public housing authorities/Indian housing authorities
Private institutions of higher education
Independent school districts
County governments
Native American tribal organizations (other than Federally recognized tribal governments)
State governments
For profit organizations other than small businesses
Additional Information on Eligibility: Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.

Additional Information

Agency Name: National Institutes of Health
Description: The mission of the NIH Countermeasures Against Chemical Threats (CounterACT) program is to develop new and improved therapeutics to treat and/or prevent injuries resulting from exposure to chemical threats. Chemical threats are toxic chemicals that could be used in a terrorist attack or accidentally released from industrial production, storage or shipping. They include traditional chemical warfare agents and toxic industrial chemicals and materials. This Funding Opportunity Announcement (FOA) requests new research applications for Cooperative Agreement Research Projects (U01s) seeking support for research on the identification of small molecule or biologic lead compounds that are excellent candidates for therapeutic development. The scope of research supported by this FOA includes confirmation of molecular targets for therapeutic development, demonstration of in vitro activity of candidate therapeutics, preliminary in vivo proof-of-concept efficacy data, preliminary adsorption, distribution, metabolism, excretion, and toxicity (ADME/Tox) evaluations and pharmacokinetics/pharmacodynamics (PK/PD) data. These studies must result in the identification of at least one lead compound ready for advanced therapeutic development. Lead compounds are biologically active and synthetically feasible compounds where specificity, affinity, potency, target selectivity, efficacy, and safety have been established. Lead compounds should be ready for more advanced development under possible support from other programs such as the one described in the companion FOA “CounterACT Optimization of Therapeutic Lead Compound (U01)” (PAR-16-XXX). The scope of this FOA encompasses Technical Readiness Level (TRL) 3 – see TRLs. Each project must include annual milestones that create discrete go or no-go decision points in a progressive translational study plan.
Link to Additional Information: http://grants.nih.gov/grants/guide/pa-files/PAR-16-129.html
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

NIH OER Webmaster

FBOWebmaster@OD.NIH.GOV

Email:FBOWebmaster@OD.NIH.GOV

DISPLAYING: Synopsis 1

General Information

Document Type: Grants Notice
Funding Opportunity Number: PAR-16-129
Funding Opportunity Title: Countermeasures Against Chemical Threats (CounterACT): Identification of Therapeutic Lead Compounds (U01)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Cooperative Agreement
Category of Funding Activity: Environment
Health
Category Explanation:
Expected Number of Awards:
Assistance Listings: 93.113 — Environmental Health
Cost Sharing or Matching Requirement: No
Version: Synopsis 1
Posted Date: Jun 15, 2016
Last Updated Date:
Original Closing Date for Applications:
Current Closing Date for Applications: Sep 11, 2018
Archive Date: Oct 12, 2018
Estimated Total Program Funding:
Award Ceiling: $300,000
Award Floor:

Eligibility

Eligible Applicants: For profit organizations other than small businesses
Special district governments
Independent school districts
City or township governments
County governments
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Native American tribal organizations (other than Federally recognized tribal governments)
Small businesses
Public and State controlled institutions of higher education
Others (see text field entitled “Additional Information on Eligibility” for clarification)
State governments
Native American tribal governments (Federally recognized)
Public housing authorities/Indian housing authorities
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Private institutions of higher education
Additional Information on Eligibility: Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.

Additional Information

Agency Name: National Institutes of Health
Description: The mission of the NIH Countermeasures Against Chemical Threats (CounterACT) program is to develop new and improved therapeutics to treat and/or prevent injuries resulting from exposure to chemical threats. Chemical threats are toxic chemicals that could be used in a terrorist attack or accidentally released from industrial production, storage or shipping. They include traditional chemical warfare agents and toxic industrial chemicals and materials. This Funding Opportunity Announcement (FOA) requests new research applications for Cooperative Agreement Research Projects (U01s) seeking support for research on the identification of small molecule or biologic lead compounds that are excellent candidates for therapeutic development. The scope of research supported by this FOA includes confirmation of molecular targets for therapeutic development, demonstration of in vitro activity of candidate therapeutics, preliminary in vivo proof-of-concept efficacy data, preliminary adsorption, distribution, metabolism, excretion, and toxicity (ADME/Tox) evaluations and pharmacokinetics/pharmacodynamics (PK/PD) data. These studies must result in the identification of at least one lead compound ready for advanced therapeutic development. Lead compounds are biologically active and synthetically feasible compounds where specificity, affinity, potency, target selectivity, efficacy, and safety have been established. Lead compounds should be ready for more advanced development under possible support from other programs such as the one described in the companion FOA “CounterACT Optimization of Therapeutic Lead Compound (U01)” (PAR-16-XXX). The scope of this FOA encompasses Technical Readiness Level (TRL) 3 – see TRLs. Each project must include annual milestones that create discrete go or no-go decision points in a progressive translational study plan.
Link to Additional Information: http://grants.nih.gov/grants/guide/pa-files/PAR-16-129.html
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV

Email:FBOWebmaster@OD.NIH.GOV

Related Documents

Packages

Agency Contact Information: NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV

Email: FBOWebmaster@OD.NIH.GOV

Who Can Apply: Organization Applicants

Assistance Listing Number Competition ID Competition Title Opportunity Package ID Opening Date Closing Date Actions
FORMS-D Use for due dates on or after May 25, 2016 PKG00221587 Jun 14, 2016 Jun 16, 2016 View

Package 1

Mandatory forms

282115 RR_SF424_2_0-2.0.pdf

282115 PHS398_CoverPageSupplement_3_0-3.0.pdf

282115 RR_OtherProjectInfo_1_3-1.3.pdf

282115 PerformanceSite_2_0-2.0.pdf

282115 RR_KeyPersonExpanded_2_0-2.0.pdf

282115 PHS398_ResearchPlan_3_0-3.0.pdf

Optional forms

282115 RR_Budget_1_3-1.3.pdf

282115 RR_SubawardBudget30_1_3-1.3.pdf

282115 PHS398_ModularBudget_1_2-1.2.pdf

282115 PHS_Inclusion_Enrollment_Report-1.0.pdf

282115 PHS_AssignmentRequestForm-1.0.pdf

2025-07-09T10:26:07-05:00

Share This Post, Choose Your Platform!

About the Author: